Monday, November 28, 2022
Mitochondrial Health

Targeting Metabesity 2020: Emerging Company Showcase – Stealth Biotherapeutics

Reenie McCarthy, CEO

Developing mitochondrial targeted therapeutics to address the mitochondrial function associated with many rare genetic diseases, neurodegenerative diseases, and common diseases of aging. Their lead compound has been shown to improve mitochondrial structure and function across multiple disease models — improving ATP production, decreasing oxidative stress and reducing inflammation, fibrosis and cell death.


Similar Posts

Leave a Reply

Your email address will not be published.